However, in the tumor tissues originated from the LV-control transfected PC9, although the activation of EGFR was obviously suppressed, the phosphorylation of PI3K and AKT was inhibited only slightly under the treatment of gefitinib (Figure 4B). This evidence concerns the gene AKT1 and neoplasm.